These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 904075)

  • 21. Acid phosphatase: its influence on the management of carcinoma of the prostate.
    Whitesel JA; Donohue RE; Mani JH; Mohr S; Scanavino DJ; Augspurger RR; Biber RJ; Fauver HE; Wettlaufer JN; Pfister RR
    J Urol; 1984 Jan; 131(1):70-2. PubMed ID: 6690751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum acid phosphatase in the assessment of response to systemic therapy in metastatic prostate cancer: comparison of radioimmune and enzymatic assays.
    Ihde DC; Belville WD; Mahan DE; Gemski MJ; Eddy JL
    Mil Med; 1982 Nov; 147(11):949-52. PubMed ID: 6817183
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of the prostatic massage on the activity of acid serum phosphatase in prostatic carcinoma].
    Ziesche HW
    Z Urol Nephrol; 1967 Aug; 60(8):529-34. PubMed ID: 5586587
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
    Pontes JE; Choe BK; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Sep; 126(3):363-5. PubMed ID: 6168779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic-enzymatic determination of prostatic acid phosphatase in human serum].
    Heil W; Rick W; Golitz B
    Internist (Berl); 1985 Aug; 26(8):523-7. PubMed ID: 3902709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
    Breitwieser P; Nöske HD
    Z Urol Nephrol; 1971 Apr; 64(4):249-56. PubMed ID: 5094006
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioimmunologic determination of prostatic acid phosphatase].
    Schweiger H; Höhn W; Rohr H; Brand K
    Internist (Berl); 1983 Jan; 24(1):51-4. PubMed ID: 6341281
    [No Abstract]   [Full Text] [Related]  

  • 30. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostication of prostatic carcinoma by serum acid phosphatase activity.
    Sharma RV; Srivastava VK; Sharma SC
    Indian J Med Sci; 1983 Jun; 37(6):99-100. PubMed ID: 6654439
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prostatic phosphatase determination in blood serum].
    Pinheiro J
    Rev Assoc Med Bras; 1965 May; 11(5):215-9. PubMed ID: 5263096
    [No Abstract]   [Full Text] [Related]  

  • 33. [Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience].
    Mannini D; Aiello E; Maver P; Corrado G; Vecchi F; Bellanova B
    Minerva Urol Nefrol; 1987; 39(4):335-41. PubMed ID: 2453928
    [No Abstract]   [Full Text] [Related]  

  • 34. Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
    Copland GT; Whitehurst GB; Pretlow TP; Boohaker EA; Bartolucci AA; Pretlow TG
    Cancer; 1983 Jul; 52(1):155-60. PubMed ID: 6189580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case report of a high serum acid phosphatase level in metastatic prostatic adenocarcinoma.
    Sullivan H; Murthy NR
    J Urol; 1971 Sep; 106(3):404. PubMed ID: 5097194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activity of phosphatase in the blood serum in prostatic carcinoma depending on the stage of the tumor].
    Wehnert J; Meissner D
    Z Urol Nephrol; 1976 Apr; 69(4):243-50. PubMed ID: 952097
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relation of serum levels of acid phosphatase in the femoral vein and the inferior vena cava in adenocarcinoma of the prostate].
    De Arruda HO; Srougi M; Wroklawski E; Mello Júnior OM; De Góes GM
    Rev Paul Med; 1981; 97(7-9):113-5. PubMed ID: 7342295
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigations on acid phosphatase activity in human plasma and serum.
    Modder CP
    Clin Chim Acta; 1973 Jan; 43(2):205-14. PubMed ID: 4687899
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum prostatic acid phosphatase: an increase associated with a metastatic carcinoid tumor.
    Martini F; Pannacciulli I
    J Natl Cancer Inst; 1991 Apr; 83(7):511. PubMed ID: 2005634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.